rs17038714

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_020822.3(KCNT1):​c.1749G>A​(p.Ala583Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.237 in 1,612,168 control chromosomes in the GnomAD database, including 50,457 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A583A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.30 ( 7877 hom., cov: 34)
Exomes 𝑓: 0.23 ( 42580 hom. )

Consequence

KCNT1
NM_020822.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -1.68

Publications

17 publications found
Variant links:
Genes affected
KCNT1 (HGNC:18865): (potassium sodium-activated channel subfamily T member 1) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a sodium-activated potassium channel subunit which is thought to function in ion conductance and developmental signaling pathways. Mutations in this gene cause the early-onset epileptic disorders, malignant migrating partial seizures of infancy and autosomal dominant nocturnal frontal lobe epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
KCNT1 Gene-Disease associations (from GenCC):
  • childhood-onset epilepsy syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 14
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • autosomal dominant nocturnal frontal lobe epilepsy 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 9-135770427-G-A is Benign according to our data. Variant chr9-135770427-G-A is described in ClinVar as Benign. ClinVar VariationId is 129353.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.68 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.463 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020822.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNT1
NM_020822.3
MANE Select
c.1749G>Ap.Ala583Ala
synonymous
Exon 17 of 31NP_065873.2
KCNT1
NM_001272003.2
c.1614G>Ap.Ala538Ala
synonymous
Exon 16 of 31NP_001258932.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNT1
ENST00000371757.7
TSL:1 MANE Select
c.1749G>Ap.Ala583Ala
synonymous
Exon 17 of 31ENSP00000360822.2
KCNT1
ENST00000460750.5
TSL:1
n.*1359G>A
non_coding_transcript_exon
Exon 17 of 32ENSP00000418777.1
KCNT1
ENST00000460750.5
TSL:1
n.*1359G>A
3_prime_UTR
Exon 17 of 32ENSP00000418777.1

Frequencies

GnomAD3 genomes
AF:
0.299
AC:
45412
AN:
152056
Hom.:
7858
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.468
Gnomad AMI
AF:
0.127
Gnomad AMR
AF:
0.207
Gnomad ASJ
AF:
0.156
Gnomad EAS
AF:
0.417
Gnomad SAS
AF:
0.354
Gnomad FIN
AF:
0.316
Gnomad MID
AF:
0.152
Gnomad NFE
AF:
0.212
Gnomad OTH
AF:
0.250
GnomAD2 exomes
AF:
0.259
AC:
64505
AN:
249284
AF XY:
0.256
show subpopulations
Gnomad AFR exome
AF:
0.481
Gnomad AMR exome
AF:
0.177
Gnomad ASJ exome
AF:
0.152
Gnomad EAS exome
AF:
0.420
Gnomad FIN exome
AF:
0.324
Gnomad NFE exome
AF:
0.208
Gnomad OTH exome
AF:
0.226
GnomAD4 exome
AF:
0.231
AC:
337040
AN:
1459994
Hom.:
42580
Cov.:
37
AF XY:
0.232
AC XY:
168726
AN XY:
726302
show subpopulations
African (AFR)
AF:
0.479
AC:
16026
AN:
33446
American (AMR)
AF:
0.181
AC:
8050
AN:
44590
Ashkenazi Jewish (ASJ)
AF:
0.157
AC:
4083
AN:
26038
East Asian (EAS)
AF:
0.437
AC:
17334
AN:
39684
South Asian (SAS)
AF:
0.317
AC:
27270
AN:
86120
European-Finnish (FIN)
AF:
0.317
AC:
16712
AN:
52794
Middle Eastern (MID)
AF:
0.152
AC:
877
AN:
5762
European-Non Finnish (NFE)
AF:
0.209
AC:
232453
AN:
1111248
Other (OTH)
AF:
0.236
AC:
14235
AN:
60312
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
13702
27403
41105
54806
68508
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8318
16636
24954
33272
41590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.299
AC:
45470
AN:
152174
Hom.:
7877
Cov.:
34
AF XY:
0.303
AC XY:
22572
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.468
AC:
19435
AN:
41492
American (AMR)
AF:
0.207
AC:
3174
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.156
AC:
543
AN:
3472
East Asian (EAS)
AF:
0.417
AC:
2152
AN:
5162
South Asian (SAS)
AF:
0.354
AC:
1707
AN:
4828
European-Finnish (FIN)
AF:
0.316
AC:
3358
AN:
10610
Middle Eastern (MID)
AF:
0.150
AC:
44
AN:
294
European-Non Finnish (NFE)
AF:
0.212
AC:
14404
AN:
67992
Other (OTH)
AF:
0.254
AC:
537
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1576
3152
4728
6304
7880
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
456
912
1368
1824
2280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.248
Hom.:
3652
Bravo
AF:
0.297
Asia WGS
AF:
0.388
AC:
1349
AN:
3478
EpiCase
AF:
0.195
EpiControl
AF:
0.189

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
2
not provided (2)
-
-
1
Autosomal dominant nocturnal frontal lobe epilepsy 5 (1)
-
-
1
Developmental and epileptic encephalopathy, 14 (1)
-
-
1
Developmental and epileptic encephalopathy, 14;C3554306:Autosomal dominant nocturnal frontal lobe epilepsy 5 (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
9.5
DANN
Benign
0.93
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17038714; hg19: chr9-138662273; COSMIC: COSV53701933; COSMIC: COSV53701933; API